Children should get doses of the Hib vaccine
at 2 and 4 months of age, at 6 months of age (for some brands of vaccine), and receive a last dose between 12 to 15 months of age.
For example, global coverage for the Hib vaccine
is 72%, but only about 44% of the world's children receive the complete course of the pneumococcal vaccine.
THURSDAY, July 12, 2018 (HealthDay News) -- Streptococcus pneumoniae and Haemophilus influenzae type b (Hib) deaths in children decreased between 2000 and 2015, following introduction of the pneumococcal conjugate vaccine (PCV) and Hib vaccine
, according to a study published in the July issue of The Lancet Global Health.
The hiatus of more than 20 years between the introduction of the mumps vaccine in 1967 and that of the Hib vaccine
in 1989 in my view was because the economic incentives to develop vaccines were absent.
However, Hib vaccine
does not cross-protect against other serotypes.
As of September 2016, a total of 191 (99%) of 194 WHO member countries had introduced Hib vaccine
, 190 (98%) had introduced hepatitis B vaccine, 132 (68%) had introduced pneumococcal conjugate vaccine (PCV), and 86 (44%) had introduced rotavirus vaccine into infant vaccination schedules.
(3) In the present study, safety and efficacy of Hib vaccine
has been studied.
Given the chemical similarities between Hia and Hib capsular polysaccharides, it has been suggested that a bivalent Hib-Hia glycoconjugate vaccine formulation with a similar CP previously used for Hib vaccine
could be utilized to induce effective immune protection against both Hia and Hib infections [14, 17].
In the years since the first Hib vaccine--a polysaccharide vaccine--was licensed in 1985, and the first conjugate Hib vaccine
was licensed in 1989, the incidence of invasive Hib infection among children aged under 5 years has dropped dramatically and has remained low through the 2000s, Dr.
The Hib vaccine
is offered to children at two, three and four months old.
TAK-816 is a Hib vaccine
licensed from Swiss Novartis (VTX: NOVN) in May 2009.
The objective of the ICMR study was to ascertain the feasibility of doing a Hib probe study to estimate the Hib vaccine
preventable disease burden.